Earlier this week 13 pharmaceutical companies*, together with several government and nongovernmental organizations**, pledged to find solutions to eliminate or control 10 neglected tropical diseases (NTDs) by the year 2020. At an event in London, pharmaceutical companies committed to invest in research and development (R&D) to find new treatments for NTDs along with increasing donations of existing drugs.

Dengue illness, the most common mosquito-borne viral disease in the world, has expanded from Southeast Asia to The Americas.

By: John O. Davies-Cole, PhD, MPH, Professor at The George Washington University

Pages